乳腺癌易感基因+2T变异产生功能性非经典供体位点影响临床解读
本研究利用5个小基因构建体涵盖ATM、BRCA1和PALB2的29个外显子,在MCF-7细胞中分析30个+2T>C/G/A变异对剪接的影响。发现部分+2T变异可产生功能性非经典5'剪接位点并生成全长转录本,其中两个变异被归类为可能良性,另两个从可能致病性重新分类为意义不明变异。变异剪接检测可为准确临床分类提供关键数据。
要点
- 部分+2T变异可产生功能性非经典供体位点,生成全长转录本。
- ATM c.6347+2T>C和BRCA1 c.5193+2T>C被归类为可能良性。
- ATM c.6347+2T>G和BRCA1 c.4675+2T>C从可能致病性重新分类为VUS。
核心结论
- 相当比例的+2T变异可创建功能性非经典5'剪接位点,产生可能保留基因功能的全长转录本。
- 变异剪接检测为准确临床分类和制定有效临床管理策略提供必要数据。
研究设计与样本
- 采用5个小基因构建体涵盖ATM、BRCA1和PALB2的29个外显子。
- 通过定点诱变引入30个+2T>C/G/A变异,在MCF-7细胞中分析。
主要发现
- 四个+2T>C变异(ATM c.6347+2T>C、BRCA1 c.5193+2T>C和c.5277+2T>C、PALB2 c.2748+2T>C)及ATM c.6347+2T>A/G产生全长转录本,占总体表达的4%-81%。
- 所有+2T>C渗漏变异保守一个6核苷酸核心序列AGgcaa。
关键数值与推荐
- 依据ACMG/AMP解读指南的ClinGen规范评估变异。
- ATM c.6347+2T>C和BRCA1 c.5193+2T>C分类为可能良性,与基于各自ACMG/AMP基因规范的预测一致。
- ATM c.6347+2T>G和BRCA1 c.4675+2T>C最初预测为可能致病性,重新分类为意义不明变异(VUS)。
临床怎么用
- 对+2T变异应进行变异剪接检测以准确临床分类。
- 剪接检测数据有助于制定患者及家族的临床管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Splicing dysregulation is a relevant mechanism of pathogenicity for variants in disease susceptibility genes. Variants affecting the critical intronic +1 and +2 GT nucleotides of the 5' splice sites (5'ss) are generally strong indicators of pathogenicity. However, some +2 T variants create functional noncanonical 5'ss that generate wildtype transcripts, hampering accurate variant interpretation and genetic counseling. We previously showed that variants PALB2 c.108+2T > C and ATM c.1898+2T > G generated significant levels of full-length (FL) transcripts by creating functional atypical GC and GG donor sites, respectively. In this study, we aimed to investigate the splicing impact of +2T variants in the breast cancer susceptibility genes ATM, BRCA1, and PALB2. For this purpose, five minigenes encompassing 29 exons of ATM, BRCA1, and PALB2 were employed. A total of 30 +2T > C/G/A variants were introduced into these constructs by site-directed mutagenesis and analyzed in MCF-7 cells. Four +2T > C variants (ATM c.6347+2T > C, BRCA1 c.5193+2T > C and c.5277+2T > C, and PALB2 c.2748+2T > C) and ATM variants c.6347+2T > A/G produced FL-transcripts (4%-81% of the overall expression). All +2T > C leaky variants conserved a central core of 6 nucleotides (AGgcaa). Variants were assessed according to the ClinGen specifications of the American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) interpretation guidelines. Two variants (ATM c.6347+2T > C and BRCA1 c.5193+2T > C) were classified as likely benign, consistent with predictions based on their respective ACMG/AMP-based gene specifications. Conversely, two variants (ATM c.6347+2T > G and BRCA1 c.4675+2T > C), initially predicted as likely pathogenic, were reclassified as variant of uncertain significance (VUS). In conclusion, a significant proportion of +2T variants can create functional noncanonical 5'ss, resulting in the production of FL-transcripts that may preserve gene function. Variant-splicing assays provide essential data for accurate clinical classification and for the development of effective clinical management strategies for patients and their families. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
引用
- Llinares-Burguet I, Sanoguera-Miralles L, Bueno-Martínez E, et al. Generation of functional noncanonical donor splice sites by +2T variants in breast cancer susceptibility genes: impact on clinical interpretation. J Pathol. 2025. PMID: 41230741. doi:10.1002/path.6497
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。